NYSE:CL

Colgate-Palmolive Stock Forecast, Price & News

$84.90

+0.15 (+0.18 %)

(As of 11/27/2020 12:00 AM ET)

Add

Compare

Today's Range

$84.30

Now: $84.90▼

$85.06

50-Day Range

$76.67

MA: $81.79▼

$85.93

52-Week Range

$58.49

Now: $84.90▼

$86.41

Volume2.19 million shs

Average Volume4.26 million shs

Market Capitalization$72.77 billion

P/E Ratio27.12

Dividend Yield2.08%

Beta0.57

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. This segment markets and sells its products to various retailers, wholesalers, and distributors. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. This segment markets and sells its products for dogs and cats through pet supply retailers, veterinarians, and e-commerce retailers. Its principal global and regional trademarks include Colgate, Palmolive, elmex, meridol, Tom's of Maine, Sorriso, Hello, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Filorga, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Beat the Market (BTM) Rank^™

1.2 Analyst's Opinion

Consensus Rating
Colgate-Palmolive has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on 7 buy ratings, 3 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $78.08, Colgate-Palmolive has a forecasted downside of 8.0% from its current price of $84.90.
Amount of Analyst Coverage
Colgate-Palmolive has only been the subject of 3 research reports in the past 90 days.

1.8 Community Rank

Outperform Votes
Colgate-Palmolive has received 478 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Colgate-Palmolive has received 858 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Colgate-Palmolive has received 64.22% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote “Outperform” if you believe CL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Yield
Colgate-Palmolive pays a meaningful dividend of 2.08%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Colgate-Palmolive has been increasing its dividend for 58 years.
Dividend Coverage
The dividend payout ratio of Colgate-Palmolive is 62.19%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Colgate-Palmolive will have a dividend payout ratio of 55.00% next year. This indicates that Colgate-Palmolive will be able to sustain or increase its dividend.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Colgate-Palmolive insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $22,315,438.00 in company stock.
Percentage Held by Insiders
Only 0.78% of the stock of Colgate-Palmolive is held by insiders.
Percentage Held by Institutions
69.34% of the stock of Colgate-Palmolive is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Colgate-Palmolive are expected to grow by 4.92% in the coming year, from $3.05 to $3.20 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Colgate-Palmolive is 27.12, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.85.
Price to Earnings Ratio vs. Sector
The P/E ratio of Colgate-Palmolive is 27.12, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 38.40.
Price to Earnings Growth Ratio
Colgate-Palmolive has a PEG Ratio of 4.60. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Colgate-Palmolive has a P/B Ratio of 67.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.02 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Toilet preparations

Sub-IndustryHousehold Products

SectorConsumer Staples

Current SymbolNYSE:CL

Previous Symbol

CUSIP19416210

CIK21665

Webwww.colgatepalmolive.com

Phone212-310-2000

Employees34,300

Debt

Debt-to-Equity Ratio6.50

Current Ratio0.97

Quick Ratio0.62

Price-To-Earnings

Trailing P/E Ratio27.12

Forward P/E Ratio27.84

P/E Growth4.6

Sales & Book Value

Annual Sales$15.69 billion

Price / Sales4.64

Cash Flow$3.46 per share

Price / Cash Flow24.53

Book Value$1.25 per share

Price / Book67.92

Profitability

EPS (Most Recent Fiscal Year)$2.83

Net Income$2.37 billion

Net Margins16.65%

Return on Equity383.88%

Return on Assets17.10%

Miscellaneous

Outstanding Shares857,169,000

Market Cap$72.77 billion

Next Earnings Date1/29/2021 (Estimated)

OptionableOptionable

$84.90

+0.15 (+0.18 %)

(As of 11/27/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

How has Colgate-Palmolive's stock been impacted by COVID-19 (Coronavirus)?

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CL stock has increased by 23.2% and is now trading at $84.90.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Colgate-Palmolive?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Colgate-Palmolive or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Colgate-Palmolive?

Wall Street analysts have given Colgate-Palmolive a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Colgate-Palmolive wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, January 29th 2021.
View our earnings forecast for Colgate-Palmolive.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) released its earnings results on Wednesday, November, 4th. The company reported $0.79 EPS for the quarter, topping analysts' consensus estimates of $0.70 by $0.09. The firm earned $4.15 billion during the quarter, compared to the consensus estimate of $4 billion. Colgate-Palmolive had a net margin of 16.65% and a return on equity of 383.88%. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.71 earnings per share.
View Colgate-Palmolive's earnings history.

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive declared a quarterly dividend on Thursday, September 10th. Shareholders of record on Friday, October 23rd will be given a dividend of $0.44 per share on Monday, November 16th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date is Thursday, October 22nd.
View Colgate-Palmolive's dividend history.

What price target have analysts set for CL?

12 brokers have issued 1-year price objectives for Colgate-Palmolive's stock. Their forecasts range from $58.00 to $90.00. On average, they expect Colgate-Palmolive's share price to reach $78.08 in the next year. This suggests that the stock has a possible downside of 8.0%.
View analysts' price targets for Colgate-Palmolive.

Are investors shorting Colgate-Palmolive?

Colgate-Palmolive saw a increase in short interest during the month of October. As of October 30th, there was short interest totaling 9,360,000 shares, an increase of 23.2% from the October 15th total of 7,600,000 shares. Based on an average trading volume of 3,320,000 shares, the short-interest ratio is presently 2.8 days. Approximately 1.1% of the company's shares are short sold.
View Colgate-Palmolive's Short Interest.

Who are some of Colgate-Palmolive's key competitors?

Some companies that are related to Colgate-Palmolive include The Procter & Gamble (PG), Kimberly-Clark (KMB), The Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS).
View all competitors.

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), The Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), The Coca-Cola (KO), Intel (INTC), McDonald's (MCD) and The Walt Disney (DIS).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the following people:

Mr. Noel R. Wallace, Chairman, CEO & Pres (Age 56, Pay $3.99M)
Mr. Henning I. Jakobsen, Chief Financial Officer (Age 60, Pay $1.72M)
Ms. Jennifer M. Daniels, Chief Legal Officer & Sec. (Age 56, Pay $1.49M)
Mr. Panagiotis Tsourapas, Group Pres of Colgate-Latin America, Asia Pacific & Africa/Eurasia (Age 55, Pay $1.58M)
Ms. Prabha Parameswaran, Group Pres of Global Innovation Group (Age 61, Pay $1.73M)
Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 61)
Mr. Mike Crowe, Chief Information Officer
John Faucher, Chief Investor Relations Officer
Valerie Haliburton, VP of Global Ethics & Compliance
Paula Davis, VP & Chief Communications Officer

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.00%), State Street Corp (6.18%), Massachusetts Financial Services Co. MA (4.19%), Charles Schwab Investment Management Inc. (0.81%), Nuveen Asset Management LLC (0.68%) and California Public Employees Retirement System (0.58%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, Prabha Parameswaran, Sally Massey and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive.

Which major investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Caisse DE Depot ET Placement DU Quebec, Harding Loevner LP, State Street Corp, AQR Capital Management LLC, Massachusetts Financial Services Co. MA, Nuveen Asset Management LLC, The Manufacturers Life Insurance Company, and Charles Schwab Investment Management Inc.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, and Sally Massey.
View insider buying and selling activity for Colgate-Palmolive.

Which major investors are buying Colgate-Palmolive stock?

CL stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Arrowstreet Capital Limited Partnership, JPMorgan Chase & Co., DekaBank Deutsche Girozentrale, Victory Capital Management Inc., AXA S.A., Voloridge Investment Management LLC, and Acadian Asset Management LLC.
View insider buying and selling activity for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $84.90.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $72.77 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings